01 Stock Market
U.S. stock futures dipped Thursday, giving back some of the sharp gains from the previous session, as traders continue to monitor the Middle East after the U.S. and Iran agreed to a two-week ceasefire.
S&P 500 futures fell 0.3% and Nasdaq 100 futures slipped 0.2%. Futures tied to the Dow Jones Industrial Average fell by 179 points, or around 0.4%.
Notable Stock Movers: AI-infrastructure specialist CRWV up 3% after sealing a multibillion-dollar cloud capacity pact with Meta. China EV maker NIO up 4.23% at $6.65 on upbeat pre-market demand signals, while peer XPEV down 3.37% at $17.20 amid profit-taking in Chinese ADRs. Chip bellwether NVDA down 0.46% at $181.24 as memory suppliers retreated after Wednesday’s surge. Storage heavyweight MU eased 0.30% at $405.50, reversing part of its recent geopolitical rebound.
02 Other Markets
• 10-year U.S. Treasury yield fell 0.14%, to 4.29%.
• U.S. Dollar Index fell 0.08% to 98.92.
• WTI crude oil futures rose 4.88% to 99.02 USD/barrel; COMEX gold futures fell 0.04% to 4,775.40 USD/ounce.
03 Key News
CoreWeave, Meta Enter into $21B Expanded AI Infrastructure Pact
CoreWeave (CRWV) shares rose 3% in premarket trading Thursday after the company announced an expanded long-term agreement with Meta Platforms (META) to provide AI cloud capacity through December 2032, valued at about $21B.
The deal builds on an existing partnership and will support Meta’s AI development, with the company using CoreWeave’s platform to scale inference workloads.
The dedicated capacity will be deployed across multiple locations and will include some of the initial deployments of the NVIDIA Vera Rubin platform (NVDA).
Amazon Cloud Unit's AI Revenue Run Rate Exceeds $15 Billion, CEO Says
Amazon.com said on Thursday its cloud business's AI revenue run rate was more than $15 billion in the first quarter of 2026, the company's first disclosure of direct financial returns from its artificial intelligence efforts.
The numbers are also "ascending rapidly", Amazon CEO Andy Jassy said in a letter to shareholders, adding that its cloud business as a whole would be growing even faster without the capacity constraints that the tech industry is currently facing.
Eli Lilly Launches New Weight Loss Pill Foundayo in U.S.
Eli Lilly (LLY) announced on Thursday that its newly approved weight loss pill Foundayo (orforglipron) will be available across U.S. retail pharmacies starting today, setting up a battle with Novo Nordisk (NVO), which launched its rival Wegovy pill earlier this year.
When the FDA approved the once-daily therapy for obese or overweight adults with weight-related medical problems earlier this month, the company began to immediately accept Foundayo prescriptions through its direct-to-consumer site, LillyDirect.
BlackBerry Forecasts Upbeat Quarterly Revenue, Says Turnaround Complete
BlackBerry on Thursday forecast first-quarter revenue above estimates, as the Canadian software company's turnaround gains traction on the back of strong demand across its cybersecurity and embedded software divisions.
U.S.-listed shares of the company jumped more than 10% in premarket trading.
Sources: Reuters, Dow Jones, Tiger Newspress, public market data
Disclaimer: For informational purposes only; not investment advice.
Comments